Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
NACRES:
NB.24
UNSPSC Code:
12190000
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarlematerial
RC,GFF,F,F (specially cleaned) separators
Quality Level
product line
Amberlite™, ORBO™
composition
Bed A, 160 mg , Bed B, 80 mg
packaging
pkg of 10 ea
manufacturer/tradename
ORBO™ 65P
technique(s)
active air sampling: suitable
O.D. × L
13-8 mm × 75 mm , OSHA Versatile Sampler (OVS)
matrix
XAD-4 (specially cleaned)
application(s)
air monitoring
environmental
industrial hygiene
compatibility
for sampling Polar and non-polar VOCs; select aldehydes
General description
ORBO™ 65P OSHA Versatile Sampler (OVS) is used for sampling both polar and non-polar volatile organic compounds (VOCs). It is particularly suitable for selecting aldehydes. The product is capped at the inlet and outlet to minimize environmental exposure.
It is commonly used as an adsorbent to collect and retain the volatile organic compound in the air samples, allowing for accurate determination of air concentrations.
It is commonly used as an adsorbent to collect and retain the volatile organic compound in the air samples, allowing for accurate determination of air concentrations.
Legal Information
Amberlite is a trademark of DuPont de Nemours, Inc.
ORBO is a trademark of Sigma-Aldrich Co. LLC
XAD is a registered trademark of The Dow Chemical Company or an affiliated company of Dow
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Perfluorooctanesulfonate (PFOS) Conversion from N-Ethyl-N-(2-hydroxyethyl)-perfluorooctanesulfonamide (EtFOSE) in male Sprague Dawley rats after inhalation exposure.
Sue C, et al.
Environmental Research, 155, 307-313 (2017)
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.